Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma—a multicenter analysis of the German working group “Stereotactic Radiotherapy”

BACKGROUND: Renal cell carcinoma (RCC) is traditionally considered to be radioresistant. Radiotherapy response rates are believed to improve with hypofractionated, high dose stereotactic body radiotherapy (SBRT). However, limited data exist regarding the role of SBRT in the treatment of pulmonary me...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Thorac Dis
Autori principali: Hoerner-Rieber, Juliane, Duma, Marciana, Blanck, Oliver, Hildebrandt, Guido, Wittig, Andrea, Lohaus, Fabian, Flentje, Michael, Mantel, Frederick, Krempien, Robert, Eble, Michael J., Kahl, Klaus Henning, Boda-Heggemann, Judit, Rieken, Stefan, Guckenberger, Matthias
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721071/
https://ncbi.nlm.nih.gov/pubmed/29268521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.10.108
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi